Cargando...
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
BACKGROUND: Using killed microorganisms or their parts to stimulate immunity for cancer treatment dates back to the end of 19(th) century. Since then, it undergone considerable development. Our novel approach binds ligands to the tumor cell surface, which stimulates tumor phagocytosis. The therapeut...
Gardado en:
| Publicado en: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5142338/ https://ncbi.nlm.nih.gov/pubmed/27927165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2982-x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|